SEI Investments
ABEO icon

SEI Investments’s Abeona Therapeutics ABEO Stock Holding History

SEI Investments’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$652K Sell
105,560
-66,900
-39% -$367K ﹤0.01% 2525
2026
Q1 		$773K Buy
172,460
+101,307
+142% +$506K ﹤0.01% 2478
2025
Q4 		$375K Buy
+71,153
New +$358K ﹤0.01% 2632

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SEI Investments's ABEO Position: Q2 2026 in Review

SEI Investments reduced its Abeona Therapeutics (ABEO) stake by 39% in Q2 2026, selling an estimated $367K and leaving 105,560 shares worth $652K. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

SEI Investments first reported a position in ABEO in Q4 2025 and has held it in 3 quarters since. The position peaked at $773K in Q1 2026. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • SEI Investments held 105,560 shares of Abeona Therapeutics worth $652K as of Q2 2026.
  • SEI Investments sold 66,900 Abeona Therapeutics shares in Q2 2026, an estimated $367K.
  • Abeona Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2525 holding.
  • SEI Investments first reported a position in Abeona Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • SEI Investments's Abeona Therapeutics position peaked at $773K in Q1 2026.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.